Volumes : Issues : Articles

Cancer Watch 2000
Cancer Watch 2001
Cancer Watch 2002
Cancer Watch 2003
Cancer Watch 2004
Cancer Watch 2005
Cancer Watch 2006
Cancer Watch 2007
Cancer Watch 2008
Cancer Watch 2009
Cancer Watch 2010
Cancer Watch 2011
Cancer Watch 2012

CW August 2003

Volume 12
Issue Number 8
August 2003
ISSN 10593802

Estrogen-Receptor Modulator to Treat Endometrial Cancer

Arzoxifene, a new orally active third-generation antiestrogen is tested for its safety and effectiveness in the treatment of advanced or recurrent endometrial cancer.
Go to Previous Page
Go to Next Page

Source & Additional Reading

T. W. Burke et al., Gynecologic Oncology, August 2003.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details.

Download Complete Issue CW August 2003

Purchase Downloadable Full-text PDF of Complete Issue: $20.00

<< Go Back to CW August 2003